Clinical Trial Update: Botulinum Toxin Type a Injection to Prevent Keloid Recurrence [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating botulinum toxin type A injections to prevent recurrence of keloids has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keloids

Drugs mentioned

• Botulinum toxin type A (botulinum toxin type A)

Snippet

Sponsor: National Cheng-Kung University Hospital | Conditions: Scar Keloid | Phase 4 | Status: COMPLETED